Abstract:Aim MicroRNAs (miRNAs) regulate β‐cell function, and β‐cell mitochondria and insulin secretion are perturbed in diabetes. We aimed to identify key miRNAs regulating β‐cell mitochondrial metabolism and novel β‐cell miRNA‐mitochondrial pathways. Methods TargetScan (http://www.targetscan.org/) was used to predict if 16 miRNAs implicated in β‐cell function target 27 cis‐eGenes implicated in mitochondrial activity. The expression of candidate miRNAs and insulin secretion after 24 and 1 h pre‐incubation in 2.8, 11.1‐ and 16.7‐mM glucose was measured in clonal INS‐1 832/13 β‐cells. MiR‐29 silenced INS‐1 832/13 cells were assessed for insulin secretion (glucose, pyruvate, and K+), target cis‐eGene expression (Ndufv3 and Ndufa10 components of mitochondrial complex I (CI)), OXPHOS (CI‐V) protein expression, and mitochondrial OXPHOS respiration/activity. The expression of differentially expressed miR‐29 miRNAs was evaluated in Goto‐Kakizaki (GK) rat, db/db mouse and type 2 diabetic (T2D) human islets, as well as NMRI mouse islets cultured under glucolipotoxic conditions. Results MiR‐29, miR‐15 and miR‐124 were predicted to regulate ~20 cis‐eGenes, while miR‐29 alone was predicted to regulate ≥12 of these in rat and human species. MiR‐29 expression and insulin secretion were reduced in INS‐1 832/13 cells after 24 h in elevated glucose. MiR‐29 knockdown increased all tested insulin secretory responses, Nudfv3, Ndufa10, complex I and II expression, and cellular mitochondrial OXPHOS. MiR‐29 expression was reduced in db/db islets but increased in GK rat and T2D human islets. Conclusion We conclude miR‐29 is a key miRNA in regulating β‐cell mitochondrial metabolism and insulin secretion via underlying miR‐29‐OXPHOS complex pathways. Furthermore, we infer reduced miR‐29 expression compensatorily enhances insulin secretion under glucotoxicity.

Mir-29A Negatively Affects Glucose-Stimulated Insulin Secretion and MIN6 Cell Proliferation Via Cdc42/β-Catenin Signaling

MiR-26b Regulates High Glucose-induced Mesangial Cell Hypertrophy Via Targeting GSK3β

MicroRNA-29b Inhibits Diabetic Nephropathy in Db/db Mice.

MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis.

MicroRNA 29 modulates β‐cell mitochondrial metabolism and insulin secretion via underlying miR‐29‐OXPHOS complex pathways

[Mir-494-3p Reduces Insulin Sensitivity in Diabetic Cardiomyocytes by Down-Regulation of Insulin Receptor Substrate 1].

Mir‐29 Contributes to Normal Endothelial Function and Can Restore It in Cardiometabolic Disorders

Mir-101A and Mir-30B Contribute to Inflammatory Cytokine-Mediated Β-Cell Dysfunction

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Mir-126 Suppresses The Glucose-Stimulated Proliferation Via Irs-2 In Ins-1 Beta Cells

Therapeutic Potential of Anti-Mir29a in Breast Cancer Patients with Type 2 Diabetes: an in Vitro and Xenograft Mouse-Model Study.

MiR-221/222 inhibit insulin production of pancreatic β-cells in mice.

Analysis of miRNA and mRNA expression in the dysregulation of insulin secretion in MIN6 cells exposed to microcystin-leucine-arginine

Circulating Mir-143-3p Inhibition Protects Against Insulin Resistance in Metabolic Syndrome Via Targeting of the Insulin-Like Growth Factor 2 Receptor.

Pancreatic Cells Control Glucose Homeostasis Via the Secretion of Exosomal Mir-29 Family

Mir-29A Regulated ER-positive Breast Cancer Cell Growth and Invasion and is Involved in the Insulin Signaling Pathway

Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family

Effect Of Mir-365 On Islet Beta Cells In High Glucose Environment Through Regulation Of Nf-Kappa B

MicroRNA-127 inhibits cell proliferation via targeting Kif3b in pancreatic β cells

Mir-192 Is Upregulated In T1dm, Regulates Pancreatic -Cell Development And Inhibits Insulin Secretion Through Suppressing Glp-1 Expression

MiR-190 ameliorates glucotoxicity-induced dysfunction and apoptosis of pancreatic β-cells by inhibiting NOX2-mediated reactive oxygen species production